FUNDING COMMITMENTFunding Commitment • April 7th, 2017 • Heat Biologics, Inc. • Pharmaceutical preparations
WHEREAS, pursuant to Section 6.13 of the Stock Purchase Agreement, dated March 7, 2017, as amended on March 29, 2017 (the “Purchase Agreement”), by and among Heat Biologics, Inc., a Delaware corporation (the “Purchaser”), Pelican Therapeutics, Inc., a Delaware corporation (the “Company”) and Josiah Hornblower, as representative of the Stockholders, Purchaser has requested that the Company provide a fully executed agreement with CPRIT with respect to the CPRIT Grant prior to the Closing; and
